Reuters2023-05-02
Pfizer Inc on Tuesday reported first-quarter profit that beat Wall Street estimates, as strong demand for its recently acquired products and pneumococcal vaccines helped offset the impact from declining sales of its COVID-19 products.
Excluding items, the U.S. drugmaker earned $1.23 per share for the quarter ended March 31, compared with estimates of 98 cents, according to Refinitiv estimates.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
抱歉，当前请求异常(-1)
Odessa Minerals Ltd-Proposed Issue of Securities - Ode
Ipeople Inc - Declaration of Cash Dividend of 0.24825 Pesos per Share Payable May 30
Indonesia's Rupiah Firms 0.4% to 16,800 per U.S. Dollar in Early Trade
Indonesia Stock Index Rises 5.6% to 6,300.611 Points in Early Trade
Harbour Biomed Appoints Youchen Chen as Chief Financial Officer
Terms and Conditions·Privacy Policy
Company: TTMF Limited. Tech supported by Xiangshang Yixin.
Email：uservice@ttm.financial